Between 1 April 2025 and 31 March 2026, the following articles were published which relate to studies that have been supported by the NIHR Sheffield Clinical Research Facility (CRF).
Interleukin-1 receptor antagonist polymorphisms in women receiving epidural analgesia who develop maternal intrapartum fever: a prospective, multicentre Mendelian randomised study (STH21650: EPIFEVER-2)
Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial (STH18069: MIROCALS-IL2)
Back to study results